UBS sees more downside and than upside in Biogen stock
Go back to UBS sees more downside and than upside in Biogen stock| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 221.07 +0.30 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $220.77 | 52 Week High | $333.65 | |||
| Open | $219.34 | 52 Week Low | $223.02 | |||
| Day High | $222.00 | P/E | 28.31 | |||
| Day Low | $218.69 | EPS | $7.81 | |||
| Volume | 647,328 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1189.41 -44.25 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1233.66 | 52 Week High | $88.16 | |||
| Open | $1234.00 | 52 Week Low | $67.88 | |||
| Day High | $1235.78 | P/E | 275.33 | |||
| Day Low | $1180.01 | EPS | $4.32 | |||
| Volume | 3,004,802 | |||||
